NEWS IN BRIEF

Austrian health agency warns against consumption of high-dose supplements

By Tim Cutcliffe contact

- Last updated on GMT

© gettyimages
© gettyimages

Related tags: Vitamin b6, Vitamin, B vitamins, European food safety authority

A product warning on supplements containing high doses of zinc and vitamin B6 was issued this week by the Austrian Agency for Health and Food Safety GmbH (AGES).

Acting on behalf of the Federal Ministry of Labour, Social Affairs, Health and Consumer Protection (BMASGK), AGES  announced that the supplements “Vitamin B complex - Capsules" and "Zinc 50 milligrams (mg)" were assessed as harmful due to their ‘excessive’ vitamin B6 and zinc contents.

The products which carry the brand label Robert  Franz Naturversand GmbH and had been available online via the website  http://robert-franz-naturversand.de​. The Austrian agency took action because they could not rule out the possibility that their own residents had purchased the product.

One capsule of the vitamin B complex provides 50mg of vitamin B6. The European Food Safety Authority (EFSA) upper daily intake limit is 25mg. EFSA warn that long-term intake above this level may cause neurological problems.  

For the 50mg zinc supplement, AGES warned that the daily tolerable intake is exceeded by 200 percent. A health hazard “cannot be ruled out​” with these quantities, they advised.

AGES stated that the warning does not attribute the cause of the excessive vitamin content of the supplement to the producer, manufacturer, importer or distributor.

However, they emphasised that consumers “are expressly warned against the consumption of these products.​”

Additionally, “AGES asks consumers not to use existing affected products, but to dispose of them immediately or to complain at the point of sale.​ “

At time of writing, the products were not available on the website.

Related news

Show more

Related products

show more

K2 for Heart Health? MenaQ7 Only Proven, Patented

K2 for Heart Health? MenaQ7 Only Proven, Patented

NattoPharma USA, Inc. | 22-Oct-2018 | Research Study

Vitamin K2 has earned media and the medical community’s attention due to a strong body of evidence showing it simultaneously supports bone and cardiovascular...

 Cannabidiol: Should you invest in it?

Cannabidiol: Should you invest in it?

The Whitehouse Consultancy | 17-Oct-2018 | Technical / White Paper

An increasing number of CBD containing products are appearing on the market and consumer interest in this substance is rising.

Human Bifidobacteria, selected by Mother’s milk

Human Bifidobacteria, selected by Mother’s milk

Morinaga Milk Industry Co., Ltd. | 13-Sep-2018 | Technical / White Paper

Health promoting traits of Bifidobacteria are well-known around the world and its effect is strain-specific, however, whether the residential origin of...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars